持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/14 | 3,730 | 3,805 | 3,710 | 3,785 | -5 | -0.1% | 45,700 |
| 2022/02/10 | 3,780 | 3,790 | 3,750 | 3,790 | ±0 | ±0% | 37,400 |
| 2022/02/09 | 3,770 | 3,810 | 3,760 | 3,790 | +30 | +0.8% | 54,700 |
| 2022/02/08 | 3,695 | 3,780 | 3,695 | 3,760 | +40 | +1.1% | 48,400 |
| 2022/02/07 | 3,630 | 3,725 | 3,630 | 3,720 | +80 | +2.2% | 47,700 |
| 2022/02/04 | 3,650 | 3,685 | 3,630 | 3,640 | -40 | -1.1% | 51,600 |
| 2022/02/03 | 3,650 | 3,715 | 3,650 | 3,680 | +25 | +0.7% | 40,600 |
| 2022/02/02 | 3,650 | 3,690 | 3,630 | 3,655 | +5 | +0.1% | 60,800 |
| 2022/02/01 | 3,560 | 3,680 | 3,560 | 3,650 | +90 | +2.5% | 81,100 |
| 2022/01/31 | 3,485 | 3,580 | 3,475 | 3,560 | +75 | +2.2% | 63,200 |
| 2022/01/28 | 3,435 | 3,525 | 3,435 | 3,485 | +85 | +2.5% | 32,600 |
| 2022/01/27 | 3,505 | 3,505 | 3,385 | 3,400 | -110 | -3.1% | 60,100 |
| 2022/01/26 | 3,550 | 3,550 | 3,510 | 3,510 | ±0 | ±0% | 26,000 |
| 2022/01/25 | 3,510 | 3,510 | 3,465 | 3,510 | -40 | -1.1% | 30,800 |
| 2022/01/24 | 3,445 | 3,550 | 3,445 | 3,550 | +60 | +1.7% | 36,500 |
| 2022/01/21 | 3,450 | 3,510 | 3,440 | 3,490 | +45 | +1.3% | 32,400 |
| 2022/01/20 | 3,360 | 3,485 | 3,360 | 3,445 | +75 | +2.2% | 33,800 |
| 2022/01/19 | 3,435 | 3,455 | 3,355 | 3,370 | -115 | -3.3% | 55,300 |
| 2022/01/18 | 3,580 | 3,580 | 3,485 | 3,485 | -85 | -2.4% | 45,900 |
| 2022/01/17 | 3,530 | 3,580 | 3,530 | 3,570 | +45 | +1.3% | 33,200 |
| 2022/01/14 | 3,500 | 3,535 | 3,485 | 3,525 | +30 | +0.9% | 42,200 |
| 2022/01/13 | 3,510 | 3,525 | 3,495 | 3,495 | -25 | -0.7% | 24,600 |
| 2022/01/12 | 3,500 | 3,540 | 3,495 | 3,520 | +55 | +1.6% | 35,500 |
| 2022/01/11 | 3,440 | 3,470 | 3,410 | 3,465 | +60 | +1.8% | 32,300 |
| 2022/01/07 | 3,420 | 3,460 | 3,395 | 3,405 | -10 | -0.3% | 40,400 |
| 2022/01/06 | 3,420 | 3,485 | 3,415 | 3,415 | -65 | -1.9% | 37,000 |
| 2022/01/05 | 3,525 | 3,540 | 3,475 | 3,480 | -40 | -1.1% | 37,300 |
| 2022/01/04 | 3,485 | 3,545 | 3,475 | 3,520 | +40 | +1.1% | 53,600 |
| 2021/12/30 | 3,475 | 3,490 | 3,460 | 3,480 | -15 | -0.4% | 16,900 |
| 2021/12/29 | 3,455 | 3,505 | 3,450 | 3,495 | +10 | +0.3% | 23,200 |
| 2021/12/28 | 3,425 | 3,490 | 3,425 | 3,485 | +75 | +2.2% | 42,700 |
| 2021/12/27 | 3,395 | 3,420 | 3,370 | 3,410 | +10 | +0.3% | 32,900 |
| 2021/12/24 | 3,395 | 3,415 | 3,390 | 3,400 | -10 | -0.3% | 17,000 |
| 2021/12/23 | 3,460 | 3,460 | 3,410 | 3,410 | -45 | -1.3% | 37,000 |
| 2021/12/22 | 3,490 | 3,495 | 3,445 | 3,455 | +5 | +0.1% | 36,600 |
| 2021/12/21 | 3,455 | 3,475 | 3,430 | 3,450 | +65 | +1.9% | 47,700 |
| 2021/12/20 | 3,380 | 3,425 | 3,380 | 3,385 | -40 | -1.2% | 33,800 |
| 2021/12/17 | 3,465 | 3,520 | 3,400 | 3,425 | -110 | -3.1% | 60,800 |
| 2021/12/16 | 3,495 | 3,545 | 3,480 | 3,535 | +70 | +2% | 46,500 |
| 2021/12/15 | 3,435 | 3,490 | 3,435 | 3,465 | +5 | +0.1% | 30,100 |
| 2021/12/14 | 3,450 | 3,490 | 3,450 | 3,460 | +10 | +0.3% | 37,800 |
| 2021/12/13 | 3,440 | 3,465 | 3,440 | 3,450 | +20 | +0.6% | 28,500 |
| 2021/12/10 | 3,475 | 3,475 | 3,410 | 3,430 | -10 | -0.3% | 39,800 |
| 2021/12/09 | 3,420 | 3,455 | 3,405 | 3,440 | -5 | -0.1% | 35,600 |
| 2021/12/08 | 3,410 | 3,455 | 3,410 | 3,445 | ±0 | ±0% | 47,900 |
| 2021/12/07 | 3,370 | 3,445 | 3,345 | 3,445 | +110 | +3.3% | 48,700 |
| 2021/12/06 | 3,355 | 3,400 | 3,330 | 3,335 | +15 | +0.5% | 97,200 |
| 2021/12/03 | 3,230 | 3,320 | 3,230 | 3,320 | +100 | +3.1% | 36,500 |
| 2021/12/02 | 3,180 | 3,265 | 3,175 | 3,220 | +15 | +0.5% | 46,300 |
| 2021/12/01 | 3,165 | 3,225 | 3,155 | 3,205 | +25 | +0.8% | 37,700 |
801～
850
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
